Ontem mesmo discutia com minha consorte (ou, segundo alguns engraçadinhos, minha conazar) sobre a idéia da gente embarcar na onda da genética popular e encomendarmos um teste genético, tal como o provido por empresas como 23andMeNavigenics, ou DecodeMe.  Pois não é que a sincronicidade universal me mandou este artigo sobre Francis Collins, um cientista que fez um exame nas 3 empresas para avaliar a qualidade dos seus resultados?

Collins, who played a central role in the Human Genome Project and is rumored to be the next head of the National Institutes of Health, announced at the Consumer Genetics Conference in Boston last week that he had had his genome analyzed by the big three of direct-to-consumer genetic testing: 23andMe, Navigenics, and DecodeMe. He ordered the tests under a fake name, lest the genomics superstar get special treatment. His speech at the conference was the first time the companies heard that they had had Collins’s DNA in hand.

Collins said that sequence-wise, the tests “appear to be highly accurate”: there were almost no differences in the genotype information generated in the three different analyses. But there were significant differences in the numbers of genetic variations used to calculate disease risk, as well as the final risk score. For example, one company used 5 single nucleotide polymorphisms, or SNPs, to calculate risk for a particular disease, pronouncing Collins at low risk. Another used 10 SNPs, placing him at high risk, and the third used 15, concluding that he is at average risk. Collins also said that the analyses provided little information on his “carrier status,” meaning whether he carried genetic risk factors that didn’t influence his own risk of disease but could be passed down to future generations.” [grifo meu]

De volta à prancheta de desenhos.